Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts
- 1 April 2018
- journal article
- research article
- Published by Elsevier BV in Journal Français d'Ophtalmologie
- Vol. 41 (4), 343-349
- https://doi.org/10.1016/j.jfo.2017.11.010
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Botulinum Toxin Type A on Oral Health in Treating Sialorrhea in Children With Cerebral Palsy: A Randomized, Double-Blind, Placebo-Controlled StudyJournal of Child Neurology, 2011
- Botulinum toxin for treatment of glandular hypersecretory disordersJournal of Plastic, Reconstructive & Aesthetic Surgery, 2008
- Botulinumtoxin bei Überfunktion der Tränendrüse, spastischem Entropium und Oberlidretraktion bei endokriner OrbitopathieDer Ophthalmologe, 2007
- Botulinum toxin treatment of secretory disordersMovement Disorders, 2004
- Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal glandEye, 2002
- Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantationBritish Journal of Ophthalmology, 2002
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlledBMJ, 2001
- Evidence-based medicine: botulinum toxin in focal hyperhidrosis.Zeitschrift für Neurologie, 2001
- Treatment of Frey’s Syndrome (Gustatory Sweating) and ‘Crocodile Tears’ (Gustatory Epiphora) With Purified Botulinum ToxinOphthalmic Plastic & Reconstructive Surgery, 2000
- Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: A case reportOphthalmology, 1999